Accession Number:

ADA558397

Title:

Medical Surveillance Monthly Report (MSMR). Volume 19, Number 3, March 2012

Descriptive Note:

Monthly rept.

Corporate Author:

ARMED FORCES HEALTH SURVEILLANCE CENTER SILVER SPRING MD

Personal Author(s):

Report Date:

2012-03-01

Pagination or Media Count:

25.0

Abstract:

After a 12-year hiatus, military recruit training centers resumed administration of adenovirus type 4 and type 7 vaccine, live, oral adenovirus vaccine to trainees beginning in October of 2011. Subsequently, rates of febrile respiratory illnesses FRI and adenovirus isolations markedly declined. These findings are consistent with those of a placebo-controlled efficacy trial conducted prior to the vaccine s licensure by the U.S. Food and Drug Administration. Continued surveillance will clarify the longer term impact of vaccine use.

Descriptors:

• *ADENOVIRUSES
• *VACCINES
• ACTIVE DUTY
• MENTAL HEALTH
• MILITARY FORCES(UNITED STATES)
• MILITARY PERSONNEL
• ORAL INTAKE
• PLACEBOS
• RECRUITS
• RESPIRATORY DISEASES
• SCHIZOPHRENIA
• THORAX
• TRAINEES
• VARIOLA VIRUS

Subject Categories:

• Microbiology

Distribution Statement:

APPROVED FOR PUBLIC RELEASE